HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Arai, T. Articles by Matsuzawa, Y. Search for Related Content PubMed PubMed Citation Articles by Arai, T. Articles by Matsuzawa, Y. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol 37, 2145-2154, Copyright © 1996 by Lipid Research, Inc.

ARTICLES

A novel nonsense mutation (G181X) in the human cholesteryl ester transfer protein gene in Japanese hyperalphalipoproteinemic subjects

T Arai, S Yamashita, N Sakai, K Hirano, S Okada, M Ishigami, T Maruyama, M Yamane, H Kobayashi, S Nozaki, T Funahashi, K Kameda-Takemura, N Nakajima and Y Matsuzawa
Second Department of Internal Medicine, Osaka University Medical School, Japan.

Cholesteryl ester transfer protein (CETP) plays an important role in regulating the concentration and composition of high density lipoprotein (HDL) and low density lipoprotein (LDL). Although several genetic abnormalities causing CETP deficiency have been identified in the Japanese subjects with a marked hyperalphalipoproteinemia (HALP), there are many CETP-deficient subjects for whom the genetic abnormalities have not been clarified. In the present study, we analyzed the molecular basis of an HALP subject without CETP activity and mass, and found a novel mutation in the CETP gene. This novel mutation (G181X) was a G-to-T substitution at codon 181 of exon 6 which replaced a codon for glycine (GGA) with a premature stop codon (TGA). The G181X mutation created a new cutting site by restriction enzyme MaeIII. To estimate the frequency of G181X, we investigated unrelated 294 HALP (HDL-cholesterol > or = 2.59 mmol/L = 100 mg/dl) subjects by restriction fragment length polymorphism (RFLP) analysis with Mae III. One (0.34%) HALP subject was homozygous and four (1.36%) were heterozygous for this mutation. The allelic frequency of a G-to-T substitution at codon 181 of exon 6 was 0.0102 in HALP subjects. From the lipid analysis of the proband and the homozygote, it was clarified that the G181X mutation had dominant effects on HDL and LDL metabolism, similar to a G-to-A substitution at the 5' splice donor site of the intron 14 (1451 + 1G-->A). In conclusion, the G181X mutation is one of causes of HALP in the Japanese HALP subjects, having dominant effects on lipid metabolism.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. M. Boekholdt, J.-A. Kuivenhoven, N. J. Wareham, R. J.G. Peters, J. W. Jukema, R. Luben, S. A. Bingham, N. E. Day, J. J.P. Kastelein, and K.-T. Khaw Plasma Levels of Cholesteryl Ester Transfer Protein and the Risk of Future Coronary Artery Disease in Apparently Healthy Men and Women: The Prospective EPIC (European Prospective Investigation into Cancer and nutrition)-Norfolk Population Study Circulation, September 14, 2004; 110(11): 1418 - 1423. [Abstract] [Full Text] [PDF]

				S. M. Boekholdt and J. F. Thompson Natural genetic variation as a tool in understanding the role of CETP in lipid levels and disease J. Lipid Res., July 1, 2003; 44(6): 1080 - 1093. [Abstract] [Full Text] [PDF]

				M. Nagano, S. Yamashita, K.-i. Hirano, M. Ito, T. Maruyama, M. Ishihara, Y. Sagehashi, T. Oka, T. Kujiraoka, H. Hattori, et al. Two novel missense mutations in the CETP gene in Japanese hyperalphalipoproteinemic subjects: high-throughput assay by Invader (R) assay J. Lipid Res., July 1, 2002; 43(7): 1011 - 1018. [Abstract] [Full Text] [PDF]

				M. Nagano, S. Yamashita, K.-i. Hirano, T. Kujiraoka, M. Ito, Y. Sagehashi, H. Hattori, N. Nakajima, T. Maruyama, N. Sakai, et al. Point Mutation (-69 G{->}A) in the Promoter Region of Cholesteryl Ester Transfer Protein Gene in Japanese Hyperalphalipoproteinemic Subjects Arterioscler. Thromb. Vasc. Biol., June 1, 2001; 21(6): 985 - 990. [Abstract] [Full Text] [PDF]

				C. W. Rittershaus, D. P. Miller, L. J. Thomas, M. D. Picard, C. M. Honan, C. D. Emmett, C. L. Pettey, H. Adari, R. A. Hammond, D. T. Beattie, et al. Vaccine-Induced Antibodies Inhibit CETP Activity In Vivo and Reduce Aortic Lesions in a Rabbit Model of Atherosclerosis Arterioscler. Thromb. Vasc. Biol., September 1, 2000; 20(9): 2106 - 2112. [Abstract] [Full Text] [PDF]

				C. Dachet, O. Poirier, F. Cambien, J. Chapman, and M. Rouis New Functional Promoter Polymorphism, CETP/-629, in Cholesteryl Ester Transfer Protein (CETP) Gene Related to CETP Mass and High Density Lipoprotein Cholesterol Levels : Role of Sp1/Sp3 in Transcriptional Regulation Arterioscler. Thromb. Vasc. Biol., February 1, 2000; 20(2): 507 - 515. [Abstract] [Full Text] [PDF]

				M. Pahor, M. B. Elam, R. J. Garrison, S. B. Kritchevsky, and W. B. Applegate Emerging Noninvasive Biochemical Measures to Predict Cardiovascular Risk Arch Intern Med, February 8, 1999; 159(3): 237 - 245. [Abstract] [Full Text] [PDF]

				C. Bruce, D. S. Sharp, and A. R. Tall Relationship of HDL and coronary heart disease to a common amino acid polymorphism in the cholesteryl ester transfer protein in men with and without hypertriglyceridemia J. Lipid Res., May 1, 1998; 39(5): 1071 - 1078. [Abstract] [Full Text]

				E. M. Teh, P. J. Dolphin, W. C. Breckenridge, and M.-H. Tan Human plasma CETP deficiency: identification of a novel mutation in exon 9 of the CETP gene in a Caucasian subject from North America J. Lipid Res., February 1, 1998; 39(2): 442 - 456. [Abstract] [Full Text]

				A. Ritsch, H. Drexel, F. W. Amann, C. Pfeifhofer, and J. R. Patsch Deficiency of Cholesteryl Ester Transfer Protein : Description of the Molecular Defect and the Dissociation of Cholesteryl Ester and Triglyceride Transport in Plasma Arterioscler. Thromb. Vasc. Biol., December 1, 1997; 17(12): 3433 - 3441. [Abstract] [Full Text]

				K.-i. Hirano, S. Yamashita, N. Nakajima, T. Arai, T. Maruyama, Y. Yoshida, M. Ishigami, N. Sakai, K. Kameda-Takemura, and Y. Matsuzawa Genetic Cholesteryl Ester Transfer Protein Deficiency Is Extremely Frequent in the Omagari Area of Japan: Marked Hyperalphalipoproteinemia Caused by CETP Gene Mutation Is Not Associated With Longevity Arterioscler. Thromb. Vasc. Biol., June 1, 1997; 17(6): 1053 - 1059. [Abstract] [Full Text]